Muscle aging and response to exercise in older adults with multiple sclerosis
Official title: Skeletal Muscle Aging and Responsiveness in Aged People With MS
Run by Oklahoma Medical Research Foundation · NCT07500727 · Data updated 2026-11-12
This study will test whether a combined cardio and strength exercise program improves muscle health and fitness for people with MS who are 60 or older compared with similar people without MS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Oklahoma Medical Research Foundation Academic / other |
| Drugs / interventions | Chemotherapy |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Status | Recruiting |
| Started | March 6, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07500727 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 60 or older with a diagnosis of MS, EDSS 2.0–5.5, cognitively able to consent, not currently in a structured exercise program, and without unmanaged chronic diseases are ideal candidates.
✕Probably not a fit
People with severe disability outside the EDSS range, unmanaged cardiopulmonary or metabolic diseases (including diabetes or liver disease), recent chemotherapy, those taking metformin, or other conditions that limit safe exercise are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The investigators will first compare baseline muscle and cardiovascular health in adults aged 60 and older with MS to age-matched people without MS. Participants will then complete a combined cardiovascular and resistance training program with visits about three times per week, roughly 1.5 hours per visit, for approximately four months. The study will measure whole-body and muscle-specific changes, including differences between a more affected and a less affected leg in people with MS, and cardiorespiratory fitness (VO2max). Results will show whether older adults with MS adapt to exercise differently than age-matched peers without MS.
Why it matters
Potential benefit: If successful, participants could gain stronger, healthier muscles, better cardiovascular fitness, and improved day-to-day mobility.
How similar studies have gone: Exercise trials in younger and middle-aged people with MS have shown benefits for strength and fitness, but few studies have focused on people over 60, so this approach is partly supported but relatively novel in this age group.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Male or female aged 60 or above 2. Free of unmanaged chronic diseases other than multiple sclerosis 3. No structured exercise program (2 or more bouts/wk) within previous 6 months 4. Cognitively capable of providing informed consent 5. Must meet EDSS score between 2 to 5.5 during screening Exclusion Criteria: * 1\. Neuromuscular or musculoskeletal disorder, other than multiple sclerosis, that would limit the ability to perform the exercise and/or testing bouts. 2\. Cardiopulmonary disorders or reduced breathing capacity 3\. Metabolic diseases including markers of liver disease (ALT \> 52 U/dl) and type 2 diabetes (HbA1C ≥ 6.5, fasting blood glucose ≥ 126 mg/dl) 4\. Taking any dose of metformin 5\. Any other disease or disorder that would influence exercise response (e.g., chronic kidney disease, Alzheimer's, current cancer diagnosis or within 2 yr remission, cerebrovascular) 6\. History of Chemotherapy within 5 years 7\. Unchangeable anticoagulant (Coumadin, Pradaxa, etc.) use. To be determined by clinical staff. 8\. Insulin sensitizing/blood glucose lowering (e.g., metformin) or metabolic (GLP1 agonists) drugs. 9\. High dose statin (40 mg and above) 10\. Have a non-correctable visual impairment 11\. Score less than 29 on the Symbol Digit Test 12\. Received Botox for spasticity within the prior 3 months of study participation. 13\. Cannot have any adjustments to Baclofen during study participation. 13\. Unable to commit to \~4 months required to complete the study. 14\. Lidocaine allergy 15\. Tobacco use 16\. Excessive alcohol consumption (3 drinks/d or 7 drinks/wk for females; 4 drinks/day or drinks/wk for males) 17\. BMI greater than 35.0 kg/m2
Where it's running
-
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, United States Recruiting
Study contacts
- Principal investigator: Benjamin F Miller, Ph.D. — Oklahoma Medical Research Foundation
- Study coordinator: Lena Fuentes
- Email: lena-fuentes@omrf.org
- Phone: 4052717745
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
Aquatic power training dosing strategies and creatine in older adults
This trial tests whether different aquatic power training dosing methods and creatine supplementation help improve function in community-dwelling adults aged 60 and older.
-
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.